001     151645
005     20240423115948.0
024 7 _ |a 10.1080/19336896.2020.1729074
|2 doi
024 7 _ |a pmid:32138593
|2 pmid
024 7 _ |a pmc:PMC7153832
|2 pmc
024 7 _ |a 1933-6896
|2 ISSN
024 7 _ |a 1933-690X
|2 ISSN
024 7 _ |a altmetric:77948932
|2 altmetric
037 _ _ |a DZNE-2020-01224
041 _ _ |a English
082 _ _ |a 570
100 1 _ |a Arora, Amandeep Singh
|0 P:(DE-2719)9000012
|b 0
|e First author
245 _ _ |a The role of cellular prion protein in lipid metabolism in the liver.
260 _ _ |a London [u.a.]
|c 2020
|b Taylor & Francis
336 7 _ |a article
|2 DRIVER
336 7 _ |a Output Types/Journal article
|2 DataCite
336 7 _ |a Journal Article
|b journal
|m journal
|0 PUB:(DE-HGF)16
|s 1713780840_6655
|2 PUB:(DE-HGF)
336 7 _ |a ARTICLE
|2 BibTeX
336 7 _ |a JOURNAL_ARTICLE
|2 ORCID
336 7 _ |a Journal Article
|0 0
|2 EndNote
520 _ _ |a Cellular prion protein (PrPC) is a plasma membrane glycophosphatidylinositol-anchored protein and it is involved in multiple functions, including neuroprotection and oxidative stress. So far, most of the PrPC functional research is done in neuronal tissue or cell lines; the role of PrPC in non-neuronal tissues such as liver is only poorly understood. To characterize the role of PrPC in the liver, a proteomics approach was applied in the liver tissue of PrPC knockout mice. The proteome analysis and biochemical validations showed an excessive fat accumulation in the liver of PrPC knockout mice with a change in mRNA expression of genes linked to lipid metabolism. In addition, the higher Bax to Bcl2 ratio, up-regulation of tgfb1 mRNA expression in PrPC knockout mice liver, further showed the evidences of metabolic disease. Over-expression of PrPC in fatty acid-treated AML12 hepatic cell line caused a reduction in excessive intracellular fat accumulation; shows association of PrPC levels and lipid metabolism. Therefore, based on observation of excessive fat globules in the liver of ageing PrPC knockout mice and the reduction of fat accumulation in AML12 cell line with PrPC over-expression, the role of PrPC in lipid metabolism is described.
536 _ _ |a 344 - Clinical and Health Care Research (POF3-344)
|0 G:(DE-HGF)POF3-344
|c POF3-344
|f POF III
|x 0
588 _ _ |a Dataset connected to CrossRef, PubMed,
650 _ 2 |a Acetyl-CoA Carboxylase: genetics
|2 MeSH
650 _ 2 |a Acetyl-CoA Carboxylase: metabolism
|2 MeSH
650 _ 2 |a Adiposity
|2 MeSH
650 _ 2 |a Animals
|2 MeSH
650 _ 2 |a Cell Line
|2 MeSH
650 _ 2 |a Electrophoresis, Gel, Two-Dimensional
|2 MeSH
650 _ 2 |a Fatty Acid Synthases: genetics
|2 MeSH
650 _ 2 |a Fatty Acid Synthases: metabolism
|2 MeSH
650 _ 2 |a Female
|2 MeSH
650 _ 2 |a Gene Expression Regulation
|2 MeSH
650 _ 2 |a Lipid Metabolism: genetics
|2 MeSH
650 _ 2 |a Liver: metabolism
|2 MeSH
650 _ 2 |a Male
|2 MeSH
650 _ 2 |a Metabolic Diseases: metabolism
|2 MeSH
650 _ 2 |a Mice, Inbred C57BL
|2 MeSH
650 _ 2 |a Mice, Knockout
|2 MeSH
650 _ 2 |a PPAR alpha: metabolism
|2 MeSH
650 _ 2 |a Prion Proteins: metabolism
|2 MeSH
650 _ 2 |a Proteome: metabolism
|2 MeSH
650 _ 2 |a Proteomics
|2 MeSH
650 _ 2 |a RNA, Messenger: genetics
|2 MeSH
650 _ 2 |a RNA, Messenger: metabolism
|2 MeSH
650 _ 2 |a Transforming Growth Factor beta1: genetics
|2 MeSH
650 _ 2 |a Transforming Growth Factor beta1: metabolism
|2 MeSH
650 _ 2 |a Triglycerides: metabolism
|2 MeSH
700 1 _ |a Zafar, Saima
|0 P:(DE-2719)9000358
|b 1
700 1 _ |a Latif, Umair
|b 2
700 1 _ |a Llorens, Franc
|0 P:(DE-2719)2811280
|b 3
700 1 _ |a Sabine, Mihm
|b 4
700 1 _ |a Kumar, Prateek
|0 P:(DE-2719)9000173
|b 5
700 1 _ |a Tahir, Waqas
|0 P:(DE-2719)9000310
|b 6
700 1 _ |a Thüne, Katrin
|0 P:(DE-2719)2811840
|b 7
700 1 _ |a Shafiq, Mohsin
|0 P:(DE-2719)9000295
|b 8
700 1 _ |a Schmitz, Matthias
|0 P:(DE-2719)9000287
|b 9
700 1 _ |a Zerr, Inga
|0 P:(DE-2719)2000058
|b 10
|e Last author
773 _ _ |a 10.1080/19336896.2020.1729074
|g Vol. 14, no. 1, p. 95 - 108
|0 PERI:(DE-600)2267671-5
|n 1
|p 95 - 108
|t Prion
|v 14
|y 2020
|x 1933-690X
856 4 _ |y OpenAccess
|u https://pub.dzne.de/record/151645/files/DZNE-2020-01224.pdf
856 4 _ |y OpenAccess
|x pdfa
|u https://pub.dzne.de/record/151645/files/DZNE-2020-01224.pdf?subformat=pdfa
909 C O |o oai:pub.dzne.de:151645
|p openaire
|p open_access
|p VDB
|p driver
|p dnbdelivery
910 1 _ |a Deutsches Zentrum für Neurodegenerative Erkrankungen
|0 I:(DE-588)1065079516
|k DZNE
|b 0
|6 P:(DE-2719)9000012
910 1 _ |a Deutsches Zentrum für Neurodegenerative Erkrankungen
|0 I:(DE-588)1065079516
|k DZNE
|b 1
|6 P:(DE-2719)9000358
910 1 _ |a Deutsches Zentrum für Neurodegenerative Erkrankungen
|0 I:(DE-588)1065079516
|k DZNE
|b 3
|6 P:(DE-2719)2811280
910 1 _ |a Deutsches Zentrum für Neurodegenerative Erkrankungen
|0 I:(DE-588)1065079516
|k DZNE
|b 5
|6 P:(DE-2719)9000173
910 1 _ |a Deutsches Zentrum für Neurodegenerative Erkrankungen
|0 I:(DE-588)1065079516
|k DZNE
|b 6
|6 P:(DE-2719)9000310
910 1 _ |a Deutsches Zentrum für Neurodegenerative Erkrankungen
|0 I:(DE-588)1065079516
|k DZNE
|b 7
|6 P:(DE-2719)2811840
910 1 _ |a Deutsches Zentrum für Neurodegenerative Erkrankungen
|0 I:(DE-588)1065079516
|k DZNE
|b 8
|6 P:(DE-2719)9000295
910 1 _ |a Deutsches Zentrum für Neurodegenerative Erkrankungen
|0 I:(DE-588)1065079516
|k DZNE
|b 9
|6 P:(DE-2719)9000287
910 1 _ |a Deutsches Zentrum für Neurodegenerative Erkrankungen
|0 I:(DE-588)1065079516
|k DZNE
|b 10
|6 P:(DE-2719)2000058
913 1 _ |a DE-HGF
|b Gesundheit
|l Erkrankungen des Nervensystems
|1 G:(DE-HGF)POF3-340
|0 G:(DE-HGF)POF3-344
|3 G:(DE-HGF)POF3
|2 G:(DE-HGF)POF3-300
|4 G:(DE-HGF)POF
|v Clinical and Health Care Research
|x 0
913 2 _ |a DE-HGF
|b Programmungebundene Forschung
|l ohne Programm
|1 G:(DE-HGF)POF4-890
|0 G:(DE-HGF)POF4-899
|3 G:(DE-HGF)POF4
|2 G:(DE-HGF)POF4-800
|4 G:(DE-HGF)POF
|v ohne Topic
|x 0
914 1 _ |y 2020
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0200
|2 StatID
|b SCOPUS
|d 2022-11-18
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0160
|2 StatID
|b Essential Science Indicators
|d 2020-01-17
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1050
|2 StatID
|b BIOSIS Previews
|d 2022-11-18
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1190
|2 StatID
|b Biological Abstracts
|d 2020-01-17
915 _ _ |a Creative Commons Attribution CC BY 4.0
|0 LIC:(DE-HGF)CCBY4
|2 HGFVOC
915 _ _ |a JCR
|0 StatID:(DE-HGF)0100
|2 StatID
|b PRION : 2021
|d 2022-11-18
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0501
|2 StatID
|b DOAJ Seal
|d 2021-09-28T11:59:09Z
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0500
|2 StatID
|b DOAJ
|d 2021-09-28T11:59:09Z
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0199
|2 StatID
|b Clarivate Analytics Master Journal List
|d 2022-11-18
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0150
|2 StatID
|b Web of Science Core Collection
|d 2022-11-18
915 _ _ |a IF < 5
|0 StatID:(DE-HGF)9900
|2 StatID
|d 2022-11-18
915 _ _ |a OpenAccess
|0 StatID:(DE-HGF)0510
|2 StatID
915 _ _ |a Peer Review
|0 StatID:(DE-HGF)0030
|2 StatID
|b DOAJ : Blind peer review
|d 2021-09-28T11:59:09Z
915 _ _ |a Article Processing Charges
|0 StatID:(DE-HGF)0561
|2 StatID
|f 2020-01-17
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0300
|2 StatID
|b Medline
|d 2022-11-18
915 _ _ |a Fees
|0 StatID:(DE-HGF)0700
|2 StatID
|d 2020-01-17
920 1 _ |0 I:(DE-2719)6000014
|k Göttingen common
|l Göttingen common
|x 0
920 1 _ |0 I:(DE-2719)5000037
|k Ext UMG Zerr
|l Ext UMG Zerr
|x 1
920 1 _ |0 I:(DE-2719)1440011-1
|k AG Zerr
|l Translational Studies and Biomarker
|x 2
980 _ _ |a journal
980 _ _ |a VDB
980 _ _ |a UNRESTRICTED
980 _ _ |a I:(DE-2719)6000014
980 _ _ |a I:(DE-2719)5000037
980 _ _ |a I:(DE-2719)1440011-1
980 1 _ |a FullTexts


LibraryCollectionCLSMajorCLSMinorLanguageAuthor
Marc 21